Frederic Mack

1.4k total citations
12 papers, 374 citations indexed

About

Frederic Mack is a scholar working on Genetics, Pulmonary and Respiratory Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Frederic Mack has authored 12 papers receiving a total of 374 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Genetics, 6 papers in Pulmonary and Respiratory Medicine and 4 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Frederic Mack's work include Glioma Diagnosis and Treatment (12 papers), Brain Metastases and Treatment (6 papers) and MRI in cancer diagnosis (2 papers). Frederic Mack is often cited by papers focused on Glioma Diagnosis and Treatment (12 papers), Brain Metastases and Treatment (6 papers) and MRI in cancer diagnosis (2 papers). Frederic Mack collaborates with scholars based in Germany, United States and Netherlands. Frederic Mack's co-authors include Martin Glas, Ulrich Herrlinger, Björn Scheffler, Niklas Schäfer, Brigitta G. Baumert, Nico Schäfer, Elke Hattingen, Moritz Stuplich, Christina Schaub and Sied Kebir and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and Cancer Treatment Reviews.

In The Last Decade

Frederic Mack

12 papers receiving 368 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Frederic Mack Germany	10	267	166	121	84	56	12	374
Moritz Stuplich Germany	11	275 1.0×	122 0.7×	121 1.0×	50 0.6×	54 1.0×	15	368
Mart A. A. M. Heesters Netherlands	8	235 0.9×	98 0.6×	186 1.5×	97 1.2×	69 1.2×	10	472
J. Curschmann Switzerland	4	331 1.2×	172 1.0×	98 0.8×	58 0.7×	65 1.2×	6	431
Despina Misailidou Greece	8	278 1.0×	183 1.1×	98 0.8×	65 0.8×	75 1.3×	9	417
E. Cohen-Jonathan Moyal France	7	239 0.9×	108 0.7×	62 0.5×	98 1.2×	81 1.4×	25	355
Ryan S. Youland United States	10	381 1.4×	142 0.9×	231 1.9×	49 0.6×	68 1.2×	20	472
Sophie E. M. Veldhuijzen van Zanten Netherlands	14	231 0.9×	97 0.6×	151 1.2×	90 1.1×	51 0.9×	37	445
J.P. Bahary Canada	11	184 0.7×	202 1.2×	64 0.5×	57 0.7×	51 0.9×	21	388
Heinrich Elinzano United States	10	273 1.0×	104 0.6×	123 1.0×	30 0.4×	54 1.0×	18	380
Mary Jane Lim-Fat Canada	10	171 0.6×	101 0.6×	73 0.6×	42 0.5×	36 0.6×	40	270

Countries citing papers authored by Frederic Mack

Since Specialization

Citations

This map shows the geographic impact of Frederic Mack's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frederic Mack with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frederic Mack more than expected).

Fields of papers citing papers by Frederic Mack

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frederic Mack. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frederic Mack. The network helps show where Frederic Mack may publish in the future.

Co-authorship network of co-authors of Frederic Mack

This figure shows the co-authorship network connecting the top 25 collaborators of Frederic Mack. A scholar is included among the top collaborators of Frederic Mack based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frederic Mack. Frederic Mack is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Schaub, Christina, Julia Tichy, Niklas Schäfer, et al.. (2016). Prognostic factors in recurrent glioblastoma patients treated with bevacizumab. Journal of Neuro-Oncology. 129(1). 93–100. 22 indexed citations

Schaub, Christina, Niklas Schäfer, Frederic Mack, et al.. (2016). The earlier the better? Bevacizumab in the treatment of recurrent MGMT-non-methylated glioblastoma. Journal of Cancer Research and Clinical Oncology. 142(8). 1825–1829. 13 indexed citations

Schäfer, Niklas, Gerrit H. Gielen, Sied Kebir, et al.. (2016). Phase I trial of dovitinib (TKI258) in recurrent glioblastoma. Journal of Cancer Research and Clinical Oncology. 142(7). 1581–1589. 26 indexed citations

Kebir, Sied, Florian Gaertner, Marcus Mueller, et al.. (2016). 18F-fluoroethyl-L-tyrosine positron emission tomography for the differential diagnosis of tumefactive multiple sclerosis versus glioma: A case report. Oncology Letters. 11(3). 2195–2198. 13 indexed citations

Mack, Frederic, Brigitta G. Baumert, Nico Schäfer, et al.. (2015). Therapy of leptomeningeal metastasis in solid tumors. Cancer Treatment Reviews. 43. 83–91. 110 indexed citations

Kebir, Sied, Rolf Fimmers, Norbert Galldiks, et al.. (2015). Late Pseudoprogression in Glioblastoma: Diagnostic Value of Dynamic O-(2-[18F]fluoroethyl)-L-Tyrosine PET. Clinical Cancer Research. 22(9). 2190–2196. 93 indexed citations

Mack, Frederic, Niklas Schäfer, Sied Kebir, et al.. (2014). Carmustine (BCNU) plus Teniposide (VM26) in Recurrent Malignant Glioma. Oncology. 86(5-6). 369–372. 14 indexed citations

Kebir, Sied, Frederic Mack, Christina Schaub, et al.. (2014). P16.17 * F-18-FET PET IMAGING FOR DIAGNOSIS OF LATE PSEUDOPROGRESSION IN PATIENTS WITH HIGH-GRADE GLIOMAS. Neuro-Oncology. 16(suppl 2). ii1–ii112. 6 indexed citations

Schaub, Christina, Susanne Greschus, Andreas Waha, et al.. (2013). FLAIR-Only Progression in Bevacizumab-Treated Relapsing Glioblastoma Does Not Predict Short Survival. Oncology. 85(3). 191–195. 13 indexed citations

10.

Kebir, Sied, K. Kuchelmeister, Pitt Niehusmann, et al.. (2012). Intravascular CNS lymphoma: Successful therapy using high-dose methotrexate-based polychemotherapy. Experimental Hematology and Oncology. 1(1). 37–37. 8 indexed citations

11.

Stuplich, Moritz, Dariusch R. Hadizadeh, K. Kuchelmeister, et al.. (2012). Late and Prolonged Pseudoprogression in Glioblastoma After Treatment With Lomustine and Temozolomide. Journal of Clinical Oncology. 30(21). e180–e183. 40 indexed citations

12.

Schäfer, Niklas, Julia Tichy, Sharmilan Thanendrarajan, et al.. (2011). Ifosfamide, Carboplatin and Etoposide in Recurrent Malignant Glioma. Oncology. 80(5-6). 330–332. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact